Gene · 488
Papers3,333
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,333
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Estrogenic Modulation of Ionic Channels, Pumps and Exchangers in Airway Smooth Muscle. | Int J Mol Sci | 2023 | 37175587 | PubTator, text mining | PubMed |
| Generation of left ventricle-like cardiomyocytes with improved structural, functional, and metabolic maturity from human pluripotent stem cells. | Cell Rep Methods | 2023 | 37159667 | PubTator, text mining | PubMed |
| Amlodipine rescues advanced iron overload cardiomyopathy in hemojuvelin knockout murine model: Clinical implications. | Front Cardiovasc Med | 2023 | 37153462 | PubTator, text mining | PubMed |
| Familial comedonal Darier's disease: a new ATP2A2 mutation with intra-family clinical heterogeneity. | Int J Dermatol | 2023 | 37132526 | PubTator, text mining | PubMed |
| A Critical Role for ERO1α in Arterial Thrombosis and Ischemic Stroke. | Circ Res | 2023 | 37132383 | PubTator, text mining | PubMed |
| Stress resilience-enhancing drugs preserve tissue structure and function in degenerating retina via phosphodiesterase inhibition. | Proc Natl Acad Sci U S A | 2023 | 37126699 | PubTator, text mining | PubMed |
| Cardiomyocyte electrophysiology and its modulation: current views and future prospects. | Philos Trans R Soc Lond B Biol Sci | 2023 | 37122224 | PubTator, text mining | PubMed |
| Generation of cardiomyocytes from human-induced pluripotent stem cells resembling atrial cells with ability to respond to adrenoceptor agonists. | Philos Trans R Soc Lond B Biol Sci | 2023 | 37122218 | PubTator, text mining | PubMed |
| Candesartan, an angiotensin-II receptor blocker, ameliorates insulin resistance and hepatosteatosis by reducing intracellular calcium overload and lipid accumulation. | Exp Mol Med | 2023 | 37121975 | PubTator, text mining | PubMed |
| PK1 from Drosophila obscurin is an inactive pseudokinase with scaffolding properties. | Open Biol | 2023 | 37121260 | PubTator, text mining | PubMed |
| Anti-Cancer SERCA Inhibitors Targeting Sorafenib-Resistant Human Papillary Thyroid Carcinoma. | Int J Mol Sci | 2023 | 37108231 | PubTator, text mining | PubMed |
| Long-Term Transcriptomic Changes and Cardiomyocyte Hyperpolyploidy after Lactose Intolerance in Neonatal Rats. | Int J Mol Sci | 2023 | 37108224 | PubTator, text mining | PubMed |
| Angiotensin II-induced calcium overload affects mitochondrial functions in cardiac hypertrophy by targeting the USP2/MFN2 axis. | Mol Cell Endocrinol | 2023 | 37100191 | PubTator, text mining | PubMed |
| FiNuTyper: Design and validation of an automated deep learning-based platform for simultaneous fiber and nucleus type analysis in human skeletal muscle. | Acta Physiol (Oxf) | 2023 | 37097015 | PubTator, text mining | PubMed |
| SERCA2a Agonist Effects on Cardiac Performance During Exercise in Heart Failure With Preserved Ejection Fraction. | JACC Heart Fail | 2023 | 37086245 | PubTator, text mining | PubMed |
| The performance of dipole charge density mapping integrated with robotic magnetic navigation in the treatment of atrial tachycardias. | J Interv Card Electrophysiol | 2023 | 37076739 | PubTator, text mining | PubMed |
| Influence of age on force and re-lengthening dynamics after tetanic stimulation withdrawal in the tibialis anterior muscle. | Eur J Appl Physiol | 2023 | 37071199 | PubTator, text mining | PubMed |
| Identification of key genes in bovine muscle development by co-expression analysis. | PeerJ | 2023 | 37070092 | PubTator, text mining | PubMed |
| Insights into the regulation of cellular Mn2+ homeostasis via TMEM165. | Biochim Biophys Acta Mol Basis Dis | 2023 | 37062452 | PubTator, text mining | PubMed |
| Overexpression of KCNJ2 enhances maturation of human-induced pluripotent stem cell-derived cardiomyocytes. | Stem Cell Res Ther | 2023 | 37061738 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/488/papers?page=17